Covered recipient · General Payments record
NAZIM MERCHANT
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$854.42
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $329.12 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $114.90 | 1 |
| GlaxoSmithKline, LLC. | $78.12 | 3 |
| PFIZER INC. | $77.30 | 4 |
| Acerta Pharma LLC | $27.16 | 1 |
| Phadia US Inc. | $16.92 | 1 |
| ABBVIE INC. | $14.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.72 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105024366 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.16 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104513698 | CMS |
| GlaxoSmithKline, LLC. | $19.59 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116134467 | CMS |
| GlaxoSmithKline, LLC. | $27.66 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116570547 | CMS |
| GlaxoSmithKline, LLC. | $30.87 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116458093 | CMS |
| PFIZER INC. | $17.41 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131689058 | CMS |
| PFIZER INC. | $18.43 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131594478 | CMS |
| PFIZER INC. | $20.10 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131760550 | CMS |
| PFIZER INC. | $21.36 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131941341 | CMS |
| Phadia US Inc. | $16.92 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067584210 | CMS |
| SANOFI-AVENTIS U.S. LLC | $114.90 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140008070 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.